Lofexidine
Code | Size | Price |
---|
TAR-T7160-1mL | 1 mL * 10 mM (in DMSO) | £95.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T7160-5mg | 5mg | £95.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T7160-50mg | 50mg | £139.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
Lofexidine is a selective α2-receptor agonist, Lofexidine reduces narcotic withdrawal symptoms.
CAS:
31036-80-3
Formula:
C11H12Cl2N2O
Molecular Weight:
259.13
Pathway:
Neuroscience; GPCR/G Protein
Purity:
0.9908
SMILES:
CC(Oc1c(Cl)cccc1Cl)C1=NCCN1
Target:
Adrenergic Receptor
References
Gorodetzky CW, Walsh SL, Martin PR,et al.A phase III, randomized, multi-center, double blind, placebo controlled study of safety and efficacy of lofexidine for relief of symptoms in individuals undergoing inpatient opioid withdrawal[J].Drug Alcohol Depend. 2017 Jul 1;176:79-88.
Pergolizzi J V , Annabi H , Gharibo C , et al. The Role of Lofexidine in Management of Opioid Withdrawal[J]. Pain and Therapy, 2018.